4 episodes
Novel and Emerging Approaches to Melanoma Management: Perspectives for the Community Clinician Medscape
-
- Health & Fitness
-
-
5.0 • 1 Rating
-
This series of 4 podcasts will include discussions with expert leaders in melanoma. The content will focus on evaluating the use of immune checkpoint inhibitors in Stage II, Stage III, and Stage IV melanoma, understanding and overcoming resistance to anti- programmed cell death protein 1 (PD-1) immunotherapy, advances in the treatment and outcomes of patients with brain metastases, and the use of adjuvant and neoadjuvant treatment approaches.
-
Expert Opinion: Use of Adjuvant and Neoadjuvant Approaches in Patients With Stage III Melanoma
Dr Davies hosts Dr Mitchell on Podcast #4 to discuss adjuvant and neoadjuvant treatment approaches for patients with melanoma.
Credit available for this activity expires: 9/23/2023
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/980272?src=mkm_podcast_addon_980272 -
Advances in the Treatments and Outcomes for Patients With Melanoma With Brain Metastases
Dr Davies hosts Dr Tawbi in a podcast focused on treatments for patients with melanoma with brain metastases.
Credit available for this activity expires: [09/14/23]
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/980050?src=mkm_podcast_series_980050 -
Understanding and Overcoming Resistance to Anti-PD-1 Immunotherapy in Melanoma
Michael Davies hosts a series of 4 podcasts with leading experts to discuss important topics in melanoma.
Credit available for this activity expires: 08/31/23
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/979092?src=mkm_podcast_series_979092 -
Evaluating the Use of Immune Checkpoint Inhibitors in Melanoma
Dr Davies hosts Dr Postow on Podcast #1 to discuss immune checkpoint inhibitors (ICIs) for melanoma patients.
Credit available for this activity expires: 8/17/2023
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/978920?src=mkm_podcast_series_978920